Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.155
+0.025 (0.80%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Voyager Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-65132.33-46.41-71.236.74
Upgrade
Depreciation & Amortization
4.734.446.195.173.82
Upgrade
Loss (Gain) From Sale of Assets
0.510.180.38--
Upgrade
Asset Writedown & Restructuring Costs
2.78----
Upgrade
Loss (Gain) From Sale of Investments
-7.97-3.63-0.020.350.03
Upgrade
Stock-Based Compensation
14.7911.159.3411.3214.93
Upgrade
Other Operating Activities
---2.47-2.46-7.7
Upgrade
Change in Accounts Receivable
81.31-83.230.487.2810.48
Upgrade
Change in Accounts Payable
2.39-0.961.99-0.06-3.44
Upgrade
Change in Unearned Revenue
-44.849.4123.73-1.72-150.68
Upgrade
Change in Other Net Operating Assets
-48.23-5.73-2.21-0.91
Upgrade
Operating Cash Flow
-15.3177.92-12.51-53.53-96.72
Upgrade
Capital Expenditures
-3.52-3.26-2.49-1.61-12.1
Upgrade
Investment in Securities
-91.34-138.39-4.8567.52125.09
Upgrade
Investing Cash Flow
-94.86-141.64-7.3465.91113
Upgrade
Issuance of Common Stock
114.0233.651.110.613.16
Upgrade
Financing Cash Flow
114.0233.651.110.613.16
Upgrade
Net Cash Flow
3.85-30.08-18.7412.9919.44
Upgrade
Free Cash Flow
-18.8374.66-15-55.13-108.81
Upgrade
Free Cash Flow Margin
-23.54%29.86%-36.67%-147.36%-63.59%
Upgrade
Free Cash Flow Per Share
-0.331.68-0.39-1.46-2.91
Upgrade
Levered Free Cash Flow
23.88-3.017.253.94-19.99
Upgrade
Unlevered Free Cash Flow
23.88-3.017.254.18-19.99
Upgrade
Change in Net Working Capital
-59.9491.61-22.86-35.3143.76
Upgrade
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q